Stock Ratings / Health Care / DNTH / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Dianthus Therapeutics Inc. (DNTH) 12-Month Stock Forecast & Price Target Cone

$82.70 +0.47% NASDAQ • Public Delayed / 60s Snapshot

Dianthus Therapeutics Inc. (DNTH) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (58/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (-26.0% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $4.63B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS TUG-OF-WAR:58% Call Buyers ($2.6M)

42% PutsMax Pain: $81.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your DNTH Position Size: $10,000

Shares at $82.70: 120.9 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $64.51

$7,800

$-2,200 (-22.0%)

12M Consensus BaseTarget $82.70

$10,000

+$0 (+0.0%)

12M Bull Case BreakoutTarget $123.77

$14,966

+$4,966 (+49.7%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$86	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$116	69%	B
JP MorganUS Large-Cap Research	HOLD	$74	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring DNTH)

✓Live walkthrough of DNTH's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

DNTH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -6.17%📐 HORIZONTAL RANGE

2026-10-30O $81.29H $83.73L $80.58C $82.38VOL 496.9K

RES: $139.2SUP: $66.06SMA50: $92.76SMA200: $85.03

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DNTH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DNTH Butterfly Map → + Track DNTH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

13.5%/yr Implied 5Y Growth

vs. -65.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DNTH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for DNTH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for DNTH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DNTH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is DNTH's 12-month stock price target?

Dianthus Therapeutics Inc. (DNTH) carries a 12-month consensus base price target of $82.7 (+0% from $82.70), with a bull-case target of $123.77 and a bear-case floor of $64.51.

Is DNTH stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates DNTH D+ (Sell — SELL) with an RQD Confidence score of 58/100.

Direct Sub-Reports: DNTH RQD Cockpit DNTH 12M Forecast DNTH Earnings & Move DNTH Dividends & DRIP DNTH Insiders & 13F DNTH Whale Options DNTH Profit Sankey DNTH News & Why